Terry Dagnon is Chief Operations Officer of Outlook Therapeutics, Inc.. Currently has a direct ownership of 653,058 shares of OTLK, which is worth approximately $3.76 Million. The most recent transaction as insider was on Apr 20, 2023, when has been sold 520,000 shares (Common Stock) at a price of $1.14 per share, resulting in proceeds of $592,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 653K
0% 3M change
0% 12M change
Total Value Held $3.76 Million

Terry Dagnon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 20 2023
SELL
Open market or private sale
$592,800 $1.14 p/Share
520,000 Reduced 44.33%
653,058 Common Stock
Jun 21 2022
BUY
Open market or private purchase
$10,500 $1.05 p/Share
10,000 Added 0.85%
1,173,058 Common Stock
Dec 06 2021
BUY
Open market or private purchase
$34,777 $1.38 p/Share
25,201 Added 2.12%
1,163,058 Common Stock
Dec 03 2021
BUY
Open market or private purchase
$14,200 $1.42 p/Share
10,000 Added 0.87%
1,137,857 Common Stock
Feb 23 2021
SELL
Open market or private sale
$33,231 $2.09 p/Share
15,900 Reduced 1.39%
1,127,857 Common Stock
Feb 12 2021
SELL
Open market or private sale
$162,435 $2.55 p/Share
63,700 Reduced 5.28%
1,143,757 Common Stock
TD

Terry Dagnon

Chief Operations Officer
Monmouth Junction, NJ

Track Institutional and Insider Activities on OTLK

Follow Outlook Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OTLK shares.

Notify only if

Insider Trading

Get notified when an Outlook Therapeutics, Inc. insider buys or sells OTLK shares.

Notify only if

News

Receive news related to Outlook Therapeutics, Inc.

Track Activities on OTLK